Medication info
Janus Tablet 25 mg (Sitagliptin Phosphate Monohydrate)

Janus Tablet 25 mg (Sitagliptin Phosphate Monohydrate)

Prescription medicationTabletOral
Ingredient · strength
Sitagliptin Phosphate Hydrate›32.125mg / 1 tablet
Manufacturer / importer
White Life Sciences Co., Ltd.
Appearance
Pink, biconvex, round film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 202400181 · Approved 2024.01.24 · Insurance code 625202330

Summary

Main use
Improves blood glucose control in patients with type 2 diabetes
Who takes it
Adults
Adult dose
For monotherapy or combination therapy, administer 100 mg once daily; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When administered in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia. Because dose adjustment according to renal function is required, evaluation of renal function is recommended before treatment with this medicine and periodically thereafter. No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). No dose adjustment is necessary in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). For patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2), administer 50 mg once daily. For patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2), administer 25 mg once daily. This medicine may be administered regardless of the timing of dialysis.

Ingredients

Manufacturer
White Life Sciences Co., Ltd.

Efficacy & effects

Improves blood glucose control in patients with type 2 diabetes

View approved original text

This medication is prescribed to help patients with type 2 diabetes control their blood sugar levels. It can be used effectively in combination with dietary and exercise therapy to manage blood glucose levels. It applies to both monotherapy and combination therapy with other treatments. This helps improve blood sugar control to maintain a healthy lifestyle.

How to take

Adult dose

For monotherapy or combination therapy, administer 100 mg once daily; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When administered in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia. Because dose adjustment according to renal function is required, evaluation of renal function is recommended before treatment with this medicine and periodically thereafter. No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). No dose adjustment is necessary in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). For patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2), administer 50 mg once daily. For patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2), administer 25 mg once daily. This medicine may be administered regardless of the timing of dialysis.

Precautions

This medication may cause hypersensitivity reactions; if allergic symptoms, skin rashes, hives, or severe skin conditions appear, stop taking it immediately and consult a doctor. While taking this medication, inflammation of the pancreas (pancreatitis) may occur, so if symptoms such as abdominal pain, nausea, or vomiting occur, notify healthcare providers immediately. Patients with type 1 diabetes or diabetic ketoacidosis should not take this medication. Patients with diminished kidney function need dosage adjustments, so regular kidney function tests and adherence to a doctor's instructions are necessary. There is a risk of hypoglycemia when taking this medication, especially when used in conjunction with insulin or sulfonylureas, so blood sugar levels should be monitored frequently, and hypoglycemia symptoms should be carefully watched. This medication may cause severe arthralgia or skin blistering diseases; if joint pain or skin abnormalities occur, notify a doctor immediately. Pregnant or breastfeeding women are advised not to take this medication, and safety and efficacy in children under 18 years have not been sufficiently established. Elderly patients are at a higher risk for reduced kidney function, so regular kidney function tests before and after taking the medication, as well as dosage adjustments, are necessary. In case of overdose, seek immediate medical attention for appropriate treatment; this medication can be partially removed through hemodialysis. Interaction with other drugs is generally low, but it is advisable to consult with a doctor or pharmacist when taking with specific medications.

Side effects

  • Severe hypersensitivity reactions
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • exfoliative skin diseases
  • acute pancreatitis
  • hypoglycemia
  • upper respiratory infections
  • nasopharyngitis
  • headache
Show 32 more
  • diarrhea
  • abdominal pain
  • nausea
  • peripheral edema
  • constipation
  • vomiting
  • severe joint pain with disability
  • bullous pemphigoid-like dermatitis
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • elevated liver enzymes
  • acute renal failure
  • pneumonia
  • diabetes complications
  • metabolic acidosis
  • falls
  • cardiac arrest
  • dyspepsia
  • dizziness
  • increased serum triglycerides
  • gastritis
  • increased low-density lipoprotein
  • hyperglycemia
  • weight loss
  • hypertension
  • hypernatremia
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air and moisture. It is recommended to maintain the storage temperature between 1 and 30 degrees Celsius at room temperature.

Appearance and packaging

Appearance

Pink, biconvex, round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.